SR 142948A
SR 142948A结构式
|
常用名 | SR 142948A | 英文名 | SR 142948A |
|---|---|---|---|---|
| CAS号 | 184162-21-8 | 分子量 | 722.313 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C39H51N5O6 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
|
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
J. Pharmacol. Exp. Ther. 280(2) , 802-12, (1997) SR 142948A, 2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylc arbamoyl)-2-isopropylphenyl)-1H-pyrazole3-carbonyl]amino] adamantane-2-carboxylic acid, hydrochloride, a new and extremely potent neurotensin (NT) receptor antagonist, has been ... |
|
|
Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
Biol. Psychiatry 29(12) , 2200-7, (2004) Antipsychotic drugs (APDs) have previously been shown to alter Fos expression in a regionally specific manner. Increases in Fos expression in the nucleus accumbens (NAcc) are common to all clinically effective APDs. In contrast, APD-induced Fos expression inc... |
|
|
Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.
Mol. Oncol. 3(3) , 204-13, (2009) Pancreatic adenocarcinomas express neurotensin receptors in up to 90% of cases, however, their role in tumor biology and as a drug target is not clear. In the present study, a stable neurotensin (NT) analog induced intracellular calcium release and intracellu... |